| Previous Close | 0.23 |
| Open | 0.25 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 0.25 - 0.27 |
| 52 Week Range | 0.23 - 1.49 |
| Volume | 9,500 |
| Avg. Volume | 10,395 |
| Market Cap | 1.01M |
| Beta | 0.79 |
| PE Ratio (TTM) | -0.23 |
| EPS (TTM) | -1.18 |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Capital Cube•last monthVisualant, Inc. :VSUL-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017
Categories: Yahoo FinanceGet free summary analysis Visualant, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Visualant, Inc. – AMETEK, Inc., MKS Instruments, Inc., Cognex Corporation, Mace Security International, Inc., ESCO Technologies Inc. and Schmitt Industries, Inc. (AME-US, MKSI-US, CGNX-US, MACE-US, ESE-US and SMIT-US) that ... Read more (Read more...)
- Business Wire•2 months ago
Visualant Granted Biological Tissue Patent
Visualant, Incorporated – an emerging leader in next-generation optical sensor technology – announced today that it has received its 11th U.S. patent. The invention relates to the use of the company’s disruptive ChromaID™ technology for identifying and analyzing biological tissue, and has many potential applications in healthcare, food safety, cosmetics and other medical, industrial and consumer markets....
- Business Wire•2 months ago
Visualant Appoints Phillip Bosua to Scientific Advisory Board
Visualant, Inc. – a provider of chromatic-based identification, authentication and diagnostic solutions, with its patented ChromaID™ technology, announced today that it has appointed Phillip Bosua to its Scientific Advisory Board.